Source: http://www.chromogenics.com/press-releases/?news_page=3&news_id=5813
Timestamp: 2018-06-20 16:41:58
Document Index: 677811037

Matched Legal Cases: ['§ 4', '§ 5', '§ 4', '§ 4', '§ 5', '§ 5']

Shareholder list after registration of the rights issue – the ten largest shareholders per February 28, 2018 - Press Releases | Chromogenics (EN)
ChromoGenics AB (publ) informs the shareholder list after the registration of the rights issue at the Swedish Companies Registration Office (Bolagsverket) at February 21, 2018.
Shareholder list from Euroclear per February 28, 2018 shows the following ten largest shareholders:
Shareholder per 2018-02-28 Ordinary shares Votes and capital
K-SVETS VENTURE AB 5 112 350 12,1%
NEW ENERGY SOLUTIONS II K/S 4 606 746 10,9%
DANSKE BANK INTERNATIONAL S.A. 1 551 225 3,7%
FORMUE NORD MARKEDSNEUTRAL A/S 1 374 661 3,3%
ULTI AB 1 296 665 3,1%
FÖRSÄKRINGSAKTIEBOLAGET, AVANZA PENSION 1 254 334 3,0%
LMK FORWARD AB 1 251 226 3,0%
NORDNET PENSIONSFÖRSÄKRING AB 1 174 318 2,8%
CASTAB AB 709 110 1,7%
BENGT JOSEFSSON UTVECKLING AB 570 000 1,4%
ÖVRIGA 23 288 360 55,2%
TOTAL 42 188 995 100,0%
Källa: Euroclear AB
The information is also available on www.chromogenics.com/investors-partners/
2018-03-08 Utfall emission tio största ägarna_ENG.pdf
Notice of extraordinary general meeting in ChromoGenics
Shareholders in ChromoGenics AB (publ) are hereby convened to the extraordinary general meeting on Friday 15 December 2017, at 13:00 at Advokatfirman Lindahl’s office on Vaksalagatan 10, Uppsala. NOTICE OF EXTRAORDINARY GENERAL MEETING IN CHROMOGENICS AB (PUBL) The shareholders in ChromoGenics AB (publ) reg. no. 556630-1809 (the “Company”) are hereby convened to the extraordinary general meeting on Friday 15 December 2017, at 13:00 at Advokatfirman Lindahl’s office on Vaksalagatan 10, Uppsala. Notification etc. Shareholders who wish to participate at the extraordinary general meeting must: on Saturday 9 December 2017 be registered in the share register kept by Euroclear Sweden AB (note that the record date is a Saturday, and therefore the shareholders must be registered in the share register at the latest on Friday the 8 December 2017), and notify his or her intention to attend the extraordinary general meeting by mail to Ullforsgatan 15, 752 28 Uppsala stating “extraordinary general meeting”, by telephone to 018-43 00 430 or by e-mail to info@chromogenics.com at the latest Wednesday 13 December 2017. Such notification shall include the shareholder’s name, personal identification number or corporate registration number (or similar), address and daytime telephone number, number of shares, details on advisors if any, and where applicable, details of representatives or proxies. Nominee-registered shares To be entitled to participate in the general meeting, shareholders whose shares are registered in the name of a nominee must temporarily re-register their shares in their own names in the share register maintained by Euroclear Sweden AB in order to be entitled to attend the general meeting. Such registration must be duly effected in the share register on Friday 8 December 2017 (since the record date is a Saturday), and the shareholders must therefore advise their nominees well in advance of such date. Proxy Shareholders represented by proxy must submit a dated proxy. If the proxy is executed by a legal person, a certified copy of the certificate of registration or equivalent must be attached. The proxy may not be valid for a period longer than five years from its issuance. The original proxy and certificate of registration should be submitted to the Company by post at the address mentioned above in due time prior to the general meeting. The Company provides a form of proxy at request and it is also available at the Company’s website, http://www.chromogenics.com/sv. Number of shares and votes As of the date of this notice, there are a total of 23 214 326 shares in the Company. The total number of votes are 23 214 326. Proposed agenda 1.	Opening of the general meeting and election of chairman of the general meeting 2.	Preparation and approval of the voting list 3.	Election of one or two persons to verify the minutes 4.	Approval of the agenda 5.	Determination as to whether the meeting has been duly convened 6.	Decision regarding adoption of new Articles of Association 7.	Resolution regarding approval of the Board’s decision to issue new so-called units, with pre-emption rights for existing shareholders 8.	Closing of the general meeting Item 1 – Opening of the general meeting and election of chairman of the general meeting Advokat Mattias Prage is proposed as chairman of the general meeting. Item 6 – The board’s proposal for decision regarding adoption of new Articles of Association In order to enable the issuance of units with pre-emption rights in accordance with item 7 of the agenda the board proposes that the shareholders’ meeting resolves to amend the articles of association regarding the limits of the Company’s share capital and the number of shares (§ 4 and § 5) in accordance with the following: Current wordingProposed wording§ 4 The share capital shall amount to at least SEK 1,800,000 and no more than SEK 7,200,000. § 4 The share capital shall amount to at least SEK 4,000,000 and no more than SEK 16,000,000. § 5 The number of shares in the company shall be at least 9,000,000 and not more than 36,000,000.§ 5 The number of shares in the company shall be at least 20,000,000 and not more than 80,000,000. For a valid resolution on the adoption of new articles of association, the proposal must be supported by shareholders representing at least two thirds of both the votes cast and the shares represented at the meeting. Item 7 – Resolution regarding approval of the Board’s decision to issue a new issue of shares, so-called units, with pre-emption rights for existing shareholders The board of directors, resolved on 16 November 2017, subject to approval by the general meeting, to issue so called units with pre-emption rights for existing shareholders on the main terms set out below. The board’s resolution implies that the Company’s share capital may be increased with not more than SEK 9 285 730,90 (of which SEK 4 642 865,45 are attributable to increase due to issue of shares and SEK 4 642 865,45 are attributable to increase due to issue of warrants) by an issue of not more than 23 214 326 new so called units on the terms and conditions set out below: Each unit consists of one (1) newly issued share in the Company and one (1) newly issued warrant in the Company of series 2017/2020. This means that a maximum of 23 214 326 new shares and a maximum of 23 214 326 new warrants may be issued. The right to subscribe for new units shall belong to those persons who on the record date for the new issue of units are recorded as shareholders of the Company, where one (1) existing share shall entitle to one (1) unit right and one (1) unit right shall entitle to one (1) unit. In the event that all new units are not subscribed for with pre-emption rights the board of directors shall, within the limit of the maximum number of units to be issued, resolve on allocation of units that are not subscribed for with pre-emption rights. Such allocation shall firstly be made to subscribers that have used subscription rights in the issue in relation to the amount of subscription rights that each subscriber has used to subscribe for new units and secondly to other subscribers in relation to subscribed amount, and if this cannot be made, through drawing of lots. To ensure that shares arising through subscription by virtue of warrants issued by the Company, shall give right to participate in the new unit issue, the subscription must be executed not later than the date set out in the terms of the warrants. If full subscription for new shares takes place by use of outstanding warrants the resolution on new issue of units shall mean that the company’s share capital shall be increased further by not more than SEK 9 372,80051 through a new issue of not more than an additional 23 432 units. The record date for participation in the new issue of shares shall be 4 January 2018. The new units are issued at a subscription price of SEK 1.75 per unit which corresponds to a subscription price of SEK 1.75 per share. The warrants are issued free of consideration. Subscription with pre-emption rights shall be made by cash payment during the period from 8 January 2018 to 22 January 2018. Subscription without pre-emption rights shall be made on a subscription list during the same period. Payment for units subscribed for without pre-emption rights shall be made by cash payment in accordance with instruction on a contract note which will be sent to those who have been allotted units. The board of directors shall have the right to extend the subscription and payment period. The new shares entitle to dividends for the first time on the first record date for dividend that take place after the issue of new shares has been registered with the Swedish Companies Registration Office and been recorded in the share register kept by Euroclear Sweden AB. Each one (1) warrant entitles to subscribe for one (1) new share in the Company for SEK 3.50 (exercise price). Subscription of shares upon exercise of the warrants shall be made in accordance with the term and conditions for the warrants during the period from 10 January 2020 to 31 January 2020. After 31 January 2020 the warrants shall not entitle to subscription. In addition, customary terms and conditions shall apply in relation to the warrants. A new share that has been issued by virtue of a warrant entitles to dividends for the first time on the first record date for dividend that take place after the subscription of new shares has been registered with the Swedish Companies Registration Office and been recorded in the share register kept by Euroclear Sweden AB. The resolution on new issue of units is subject to approval by the general meeting and requires that the company’s articles of association are amended. The managing director, or any other person appointed by the board of directors, shall have the right to take those smaller measures that may be required in order to register the resolution with the Swedish Companies Registration Office and Euroclear Sweden AB. Information at the Extraordinary General Meeting The board of directors and the managing director shall, upon request by any shareholder and where the board of directors determines that it can be done without material harm to the Company, provide information of circumstances which may affect the assessment of a matter on the agenda. Documentation The board of directors’ complete proposal under items 6-7 above as well as other documents according to the Swedish Companies Act will be held available at the Company’s office (address above) and on the website www.chromogenics.com not later than two weeks before the meeting, i.e. not later than Friday 1 December 2017. The documents will also be sent, without charge, to shareholders who so request and inform the Company of their postal address. The documents will also be held available at the extraordinary general meeting. Uppsala in November 2017 ChromoGenics AB (publ) The board of directors Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on November 17, 2017. Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation. About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.
ChromoGenics targets an offensive market expansion and announces a rights issue with pre-emption rights of ca 40 MSEK
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, NEW ZEALAND, SOUTH AFRICA, CANADA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE. SummaryThe board of directors of ChromoGenics AB (publ), (“ChromoGenics”, the “Company”) has resolved to issue new shares and warrants (units) (the “Rights Issue”), subject to approval by an extraordinary general meeting on 15 December 2017. Upon full subscription in the Rights Issue, the Company raises approx. 40.6 MSEK, before transaction costs. If all warrants are exercised, the Company raises an additional approx. 81 MSEK. Anyone registered as a shareholder in ChromoGenics on 4 January, has a pre-emptive right to subscribe for units in the Rights Issue, where one (1) existing share entitles to one (1) unit right. One (1) unit right entitles to subscription for one (1) unit, consisting of one (1) share at a subscription price of SEK 1.75 per share and one (1) warrant against no consideration. The subscription period for units starts (including) 8 January and ends (including) 22 January 2018. Each warrant entitles to subscription for one (1) new share in the Company for SEK 3.50 (the exercise price) during the period from and including 10 January 2020 until and including 31 January 2020. The proceeds from the Rights Issue are intended to fund and enable an offensive expansion of ConverLight™ in the European market as well as investments in the production process. Summary of the background and reasons for the Rights Issue A sustainable and appreciated product. ChromoGenics’ business is based on world leading research which has resulted in edge competence and leading products in dynamic glass with controllable heat and light transmission. The Company’s unique electrochromic technology, ConverLight™, gives a sustainable solar control with increased indoor comfort and energy efficiency and contributes to environmental certifications of buildings. In addition to these unique qualities, the products have sustainable and environmentally sound attributes that make them attractive in a society where sustainability is becoming increasingly important, driven by knowledge as well as regulations. On the right track. The product is a very competitive replacement for awnings and other exterior solar control products and there is great interest for the products on the market. During 2017, the Company has received several important customer references, such as Atrium Ljungberg, Fabege and Skellefteå kommun, where sustainability as well as maintenance cost and investments related economic advantages have been the basis of the deals. Customers are very pleased with the initial projects. There have been initial disturbances in the production process, which negatively affects the result for 2017. The production process has gradually improved during the year. To finance further expansion, additional cash and a solid balance sheet are required. Ready for the next step. ChromoGenics is now ready of the next step in the development. Substantial market expansion – The market for dynamic glass is expected to grow significantly during the coming years, according to the American analytics company n-tech Research. ChromoGenics addresses commercial real estate, and has the ambition to materially increase its sales revenue. Market expansion in the rest of Europe – Offensive sales activities are carried out and market presence is increased in the rest of Europe. Shorter lead times in sales – the Company increases the pace in so called retro-fit sales, where current ineffective glass and solar control products are upgraded to ConverLight™. Solid balance sheet – Stronger finances enables business with customers that request a strong balance sheet. Lower costs and higher production efficiency – the Company intends to invest in production equipment for increased capacity and significantly decreased unit costs. In order to support ChromoGenics strategic initiative, the board of directors has resolved to carry out a rights issue, such resolution is subject to approval by the extraordinary general meeting. As per 30 September, cash and cash equivalents amounted to 57 MSEK, compared to the net proceeds of 78 MSEK raised by the Company through the unit issue in connection with the IPO in March 2017. The Rights Issue strengthens the Company’s balance sheet and secures continued market expansion and necessary investments in the production process, for better cost efficiency and profitability. Construction projects involve long lead times, which tie up working capital. The proceeds from the Rights Issue are intended to fund Sales- and marketing costs and investments in the production process. Issue of units with pre-emption rights On 16 November 2017, the board of directors of ChromoGenics resolved, subject to approval by the extraordinary general meeting, to carry out an issue of units with pre-emption rights for the Company’s existing shareholders. Upon full subscription in the Rights Issue, the Company raises 40.6 MSEK, before transaction costs. Anyone registered as a shareholder in ChromoGenics on 4 January 2017, has a pre-emptive right to subscribe for units in the Rights Issue, where one (1) existing share entitles to one (1) unit right. One (1) unit right entitles to subscription for one (1) unit, consisting of one (1) share at a subscription price of SEK 1.75 per share and one (1) warrant against no consideration. The subscription price amounts to SEK 1.75 per unit. Of the subscription price per unit, the subscription price per share represents SEK 1.75. The subscription period for units starts (including) 8 January and ends (including) 22 January 2018. In the Rights Issue, a maximum of 23 214 326 new shares will be issued, corresponding to an increase of the share capital with maximum SEK 4 642 865.45. In addition, a maximum of 23 214 326 new warrants will be issued. One (1) warrant entitles to subscription for (1) new share at a subscription price of SEK 3.50 during the period from and including 10 to 31 January 2020 (when the warrants will lapse). As a consequence of the issue of warrants, ChromoGenics’ share capital may be increased with an additional SEK 4 642 865.45, and the total number of shares may increase with 23 214 326 new shares. The Rights Issue is subject to approval by the extraordinary general meeting to be held on 15 December 2017 and is also subject to approval of new articles of association. Notice of the extraordinary general meeting is announced today in a separate press release. Complete terms and instructions for the Rights Issue and other information about the Company will be presented in the prospectus which will be announced before the start of the subscription period. Indicative timetable15 December 2017Extraordinary general meeting to approve the board of directors’ resolution on the Rights Issue2 January 2018Last day of trade for ChromoGenics shares, including a right to participate in the Rights Issue4 January 2018Record date for the right to participate in the Rights Issue8 January – 22 January 2018Subscription period8 January – 18 January 2018Trade with unit rightsAbout 26 January 2018Announcement of preliminary outcome of the Rights Issue Due to the timetable above, the Company has decided to postpone its Year-end report 2017 from Wednesday 31 January 2018 to Friday 23 February 2018. Financial and legal advisors regarding the Rights Issue Evli Bank Plc. is financial advisor and Advokatfirman Lindahl KB is legal advisor to ChromoGenics in connection with the issue. For more information, please contact Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications +46 (0)18 430 04 30 info@chromogenics.com Certified Adviser: G&W Fondkommission This information constitutes such information that ChromoGenics AB (publ) is obligated to disclose in accordance with the EU Market Abuse Regulation. The information was submitted by the above-mentioned contact persons for publication on 17 November 2017, at 8:30 a.m. CET. Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation. IMPORTANT INFORMATION The information in this press release does not constitute an offer to acquire, subscribe for or otherwise trade in shares or other securities in ChromoGenics. Any invitation to the persons concerned to subscribe for shares in ChromoGenics will only be made through the prospectus referred to in this press release. This press release may not be released, published or distributed, directly or indirectly, in or into the United States, Australia, Canada, Japan, New Zealand, South Africa or any other jurisdiction where such action is wholly or partially subject to legal restrictions or where such action would require additional prospectuses, registrations or other actions in addition to those required under Swedish laws and regulations. Nor may the information in this press release be forwarded, reproduced or disclosed in a manner that contravenes such restrictions or would entail such requirements. Failure to comply with this instruction may result in a violation of applicable securities laws. No shares have been or will be registered under the U.S. Securities Act of 1933, as amended ("Securities Act"), or securities legislation in any state or other jurisdiction in the United States, and may not be offered or sold, directly or indirectly, in or into the United States, except pursuant to an available exemption from the registration requirements of the Securities Act and in compliance with the securities laws of any state or other jurisdiction of the United States. This press release may contain forward-looking statements which reflect ChromoGenics's current view on future events and financial and operational development. The words "intend", "estimate", "expect", "may", "plan", "anticipate" or similar expressions regarding indications or predictions of future developments or trends and which are not statements based on historical facts constitute forward-looking information. Although ChromoGenics believes that these statements are based on reasonable assumptions and expectations, ChromoGenics cannot give any assurances that such statements will materialize. Forward-looking statements are in its nature involved with both known and unknown risks and uncertainties, since it is depending on future events and circumstances. Forward-looking statements do not constitute any representations and warranties, and the outcome could differ materially from the information set out in the forward-looking statements. About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.
ChromoGenics expands to Denmark and appoints Michael Felthaus to drive sales
Michael Felthaus has been appointed Business developer and will be responsible for sales in Denmark. This appointment reflects ChromoGenics’ strong ambition to expand its operations outside Sweden. Michael has a solid sales and business development background with more than 20 years of various positions within dynamic façade solutions in the glass as well as in the solar control industry. He has several years at WindowMaster, a part of VKR INWIDO/Art Andersen. “We are pleased to have Michael joining us to expand our business into Denmark. Michael brings proven successful sales development from the window and glass industry,” says Peter Lundh, Head of Sales at ChromoGenics. “We are in an exciting expansion phase and together with Michael we will aggressively launch our product ConverLight™ to the Danish market.” "I am excited to join ChromoGenics,” says Michael Felthaus. "ConverLight™ is well positioned to provide real estate owners, architects and construction companies with sustainable dynamic glass solutions that also contributes to environmental certifications. There is a great interest in the product and I look forward to contributing to the continued success of ChromoGenics,” concludes Michael. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.
Positive acknowledgements from customers lead to the launch of ConverLight™ in Denmark!
Interim report January – September 2017 Third quarter of 2017 Net sales for the period amounted to SEK 3.3 (1.0) million. Earnings for the period amounted to SEK -13.5 (-10.2) million, which corresponds to earnings per share of SEK -0.58 (-1.37). During the quarter, ChromoGenics invoiced and completed deliveries of dynamic glass to the head office of the Swedish Energy Agency, an office within Saldeen Real Estate and the first partial delivery to Atrium Ljungberg’s project Gränbystaden in Uppsala. ChromoGenics has appointed Michael Felthaus to market and drive sales of ConverLight™ in Denmark. ChromoGenics is in an expansion phase and the progress is going according to the plan. The new share issue in conjunction with the IPO in March 2017 brought in net SEK 78 million. Cash and cash equivalents as at September 30 amounted to SEK 57 million. The Board is continuously working with securing the company’s long-term financial position. 20172016201720162016SEK millionJul-SepJul-SepJan-SepJan-SepJan-DecNet sales 3,3 1,0 6,1 2,8 3,0EBITDA -12,0 -8,6 -32,7 -33,1 -42,2Net income -13,5 -10,2 -37,4 -37,8 -49,5EPS before dilution, SEK -0,58 -1,37 -1,95 -6,57 -7,60EPS after dilution, SEK -0,58 -1,37 -1,95 -6,57 -7,60Cash and cash equivalents at end of the period 56,7 2,1 56,7 2,1 8,5 “We are now taking the next step by launching ConverLight™ in Denmark!” Comments from the CEO Our products are receiving a lot of interest from the market, and I am convinced that this is just the beginning of a successful growth journey for ChromoGenics. Our dynamic glass ConverLight™ offers property owners, architects, energy consultants, construction companies and players in the window and facade glass industry an attractive and cost-efficient solution for solar control. ConverLight™ increases the energy efficiency and indoor comfort of buildings and contributes to environmental certifications, which is high on the environmental agenda for the sustainability work of both the EU and the commercial sector. We are now taking the next step by launching ConverLight™ in Denmark with Michael Felthaus in the lead. Michael has a solid background within the glass and façade industry and will position the company in the Danish market. We are also speeding up within retro-fit sales, where existing, inefficient glass and solar protection are upgraded to ConverLight™. During the quarter, deliveries of dynamic glasses to two retro-fit projects were completed: the head office of the Swedish Energy Agency in Eskilstuna and an office buildling owned by the real estate company, Saldeen Real Estate. The office building had previously had extensive problems with high heat radiation. Considerable amounts of energy were consumed for cooling, which resulted in unnecessarily high costs and a negative impact on the environment. ChromoGenics’ energy-effective technology has lowered the need to cool the building and the indoor climate has become much more comfortable. These are fantastic customer references for us as we take the next step in our expansion. We also completed the first partial delivery to the Atrium Ljungberg’s project Gränbystaden in Uppsala during the quarter. The plan is to inaugurate the project prior to the 2018 Christmas holiday shopping season. After another successful Dynamic Glass Academy seminar, we are now taking the concept further in Sweden and Denmark. Through the seminar we create awareness and knowledge about the company’s dynamic glass among customers and stakeholders as well as awareness about energy efficiency and comfort in buildings, with a focus on sustainability. The considerable interest we are meeting from various industry representatives confirms that our unique technology is creating good opportunities for continued successful expansion and future profitability! Thomas Almesjö, CEO Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com This information constitutes such information that ChromoGenics AB (publ) is obligated to disclose in accordance with the EU Market Abuse Regulation. The information was submitted by the above-mentioned contact persons for publication on October 26, 2017, at 8:30 a.m. CET. About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.
ChromoGenics’ order to deliver dynamic glass to the Swedish Energy Agency’s new headquarters completed
ChromoGenics AB (publ) has completed the order to deliver dynamic glass to the Swedish Energy Agency's newly opened headquarters in Eskilstuna. ChromoGenics’ dynamic glass, installed in the entrance to the new headquarters, will contribute to increased energy efficiency and indoor comfort. During the third quarter, ChromoGenics delivered and installed ConverLight™ dynamic glass to the Swedish Energy Agency's new headquarters in Eskilstuna, which was recently inaugurated. A building of a former metal foundry has been transformed into an activity-based office, fully adapted to the activities of the Swedish Energy Agency. "We focus on creating energy-efficient solutions by using new technologies. Our headquarters in Eskilstuna has put great emphasis on energy-efficient materials and solutions in our selections. We focus on the whole life cycle analysis when selecting technology and materials. Our office should be modern, comfortable and with high energy efficiency," says Kerstin Jansson, Project manager from the Department of Administration and Development at the Swedish Energy Agency. "ConverLight™ dynamic glass was chosen for its energy efficiency and indoor comfort. This is an excellent solar control solution for us since environment and sustainability are high on our agenda," concludes Kerstin Jansson at the Swedish Energy Agency. "We are proud to be part of this highly prestigious project focused on sustainable building and energy-efficient solutions," says Thomas Almesjö, CEO of ChromoGenics. "It is inspiring to collaborate with companies and associations that are at the forefront of innovative technology in energy efficient solutions. Our product ConverLight™ controls heat and light emittance while maintaining daylight and full view to the outside world. This results in energy savings and increases the comfort and well-being of people staying in the building. In addition, ConverLight™ contributes to environmental certification of buildings, which is high on today's agenda within companies and associations that are committed to helping achieve the European and global environmental and sustainability goals." concludes Thomas Almesjö. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. www.chromogenics.com About the Swedish Energy Agency The Swedish Energy Agency works for a sustainable energy system, combining ecological sustainability, competitiveness and security of supply. For a more efficient energy use, the Agency supports the development and dissemination of knowledge targeted at households, industry, and the public sector. The Swedish Energy Agency is subordinate to the Ministry of the Environment and Energy, and regulated by the Government through the instruction and annual appropriations directives. Parliament and the Government decide on the assignments and budget of the Agency. Contact: Kerstin Jansson, Department of administration and development Tel: +46 (0)16 544 20 00 www.energimyndigheten.se
ChromoGenics’ seminar creates interest in the building and real estate sector for a sustainable society
ChromoGenics AB (publ) welcomed guests from the real estate industry to Dynamic Glass Academy, a seminar on energy efficiency and comfort in building focused on sustainability. To meet the great interest in the company's dynamic glass ConverLight™, ChromoGenics invited architects, real estate companies, energy consultants and other stakeholders in the real estate industry in Uppsala to another seminar "Dynamic Glass Academy". Guest speakers presented the latest in sustainability trends, energy efficiency and sustainable materials and product selection in building. "Our ConverLight™ product provides buildings with dynamic solar and climate control, resulting to improved energy efficiency and indoor comfort. ConverLight™ also contributes to environmental certification of buildings. Buildings accounts for about a third of CO2 emissions today. We meet a lot of interest since energy efficiency and sustainability are high on the agenda in the real estate industry. The European environmental goals target that CO2 emissions shall be reduced by 20 percent by 2020, so the industry must act now," says Thomas Almesjö, CEO of ChromoGenics. "Today's tough requirements on energy efficiency, comfort as well as demand for environmental certifications have made simulation models for buildings’ performance more and more used. We help decision makers with supporting documentations for energy efficiency in buildings," says Anton Clarholm from Project Engagement. "The simulations we have performed, comparing ConverLight™ with traditional solar protections, show a significant improvement in energy performance and solar heat load in buildings while maintaining daylight," concludes Anton. "Property owners place higher demands on energy efficiency and comfort in buildings. ConverLight™ solves a problem in buildings as the market trend goes towards more glass in building. This without having to make aesthetic claims on the exterior facade," says Fredrik Bjälkensäter, Project Manager at Fasadglas in Uppsala AB, who visited Dynamic Glass Academy. "It is clear that ConverLight™ dynamic glass is right in time for a more sustainable future. We will now take the Dynamic Glass Academy event to Stockholm, Gothenburg and Malmö," concludes Thomas Almesjö, CEO of ChromoGenics. If you are interested to participate in future events, please contact info@chromogenics.com Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.
ChromoGenics has signed order for energy efficient smart windows to office building in Uppsala
ChromoGenics AB (publ) has signed an agreement with the real estate company Saldeen Real Estate AB about providing dynamic glass for solar control to an existing office property in Uppsala. The energy-saving windows replaced the previous solar protection solution. "The office has previously had extensive problems with dazzling sun and high heat irradiation. A lot of cooling has been needed to lower the temperature, which required a lot of energy. With ChromoGenics’ energy-efficient technology, cooling needs have decreased and the indoor climate has become much more comfortable since the windows were installed. The tenants are satisfied and that makes med glad too," said Bo Saldeen, CEO of Saldeen Real Estate. Bo Saldeen previously considered investing in a larger cooling system and exterior solar protection, but the options were discarded due to that maintenance costs for awnings and similar solutions are often high, they change the appearance of the façades and daylight is deprived. “We have improved our working environment with a more comfortable climate and the dazzling sun rays are no longer a problem. In addition, we get the daylight people need and there is no longer need for curtains that shut the daylight out," says Fredrik Larsson, COO at VHD-Media, whose office is in the property. “Satisfied tenants are important to all property owners and we are pleased that our dynamic glass can contribute to it, while reducing environmental impact through lower energy consumption. Sustainability is high on the agenda for all property owners,” says Thomas Almesjö, CEO of ChromoGenics. “The order shows a need for property owners to upgrade their existing properties with energy efficient solutions. It is possible to save a lot of energy in existing properties and premises, thereby lowering carbon dioxide emissions," concludes Thomas Almesjö. ChromoGenics’ dynamic glass automatically controls heat and light emitting on premises, providing better indoor comfort and lower energy consumption. The cooling need of premises can be reduced by 20-40 percent. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.
ChromoGenics has appointed Åsa Stroofe as Chief Marketing Officer
ChromoGenics is accelerating its commercialization of ConverLight™ dynamic glass for solar control given the increasing demand for energy efficiency in buildings. Åsa Stroofe has been appointed Chief Marketing Officer, CMO, from November 1st 2017 and will be part of the company’s executive management team. With a B.Sc. in Physiological Science and master classes in Marketing Management, Åsa has more than 20 years of strategic and tactical experience from both international corporations and start-ups. She has held several global marketing roles, most recently at Thermo Fisher Scientific. “We are pleased to have Åsa with us to drive our marketing strategy. Åsa brings vast experience in establishing new technologies globally,” says Thomas Almesjö, CEO of ChromoGenics. “We are now in an exciting commercialization phase and with Åsa’s customer-centric approach, we will strengthen ChromoGenics’ market position.” "I am delighted to join the energetic team at ChromoGenics,” says Åsa. "Bringing a unique sustainable solution for solar control to the real estate market is exciting. ConverLight™ dynamic glass enables property owners, architects and construction companies to decrease energy consumption and improve indoor comfort while preserving natural daylight and views. I look forward to contributing to the continued success of ChromoGenics,” concludes Åsa. Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.
Interim report January – June 2017
Large order of dynamic glass to Atrium Ljungberg’s project Gränbystaden, Uppsala Second quarter of 2017 •	ChromoGenics received a large order to deliver approximately 600 m2 of dynamic glass to Atrium Ljungberg’s project Gränbystaden, Uppsala. •	The ConverLight™ product is generating considerable interest among real estate owners, architects energy consultants and other players in the window and façade glass market. •	Net sales for the period amounted to SEK 1.7 (1.8) million. ConverLight™ is still in its initial phase of sales and production. •	Net income for the period amounted to SEK -10.5 (-15.3) million, which corresponds to earnings per share of SEK -0.46 (-2.82). •	The new share issue that was completed in February – March was fully registered with the Swedish Companies Registration Office on April 7, 2017. •	At the annual general meeting, ChromoGenics strengthened the Board with Mari Broman and Peter Gustafson, both with background within the real estate and finance industry. 20172016 2017 2016 2016 SEK millionApr-Jun Apr-JunJan-JunJan-JunJan-DecNet sales1,71,82,81,83,0EBITDA-9,0-13,7-20,7-24,4-42,2Net income-10,5-15,3-23,8-27,6-49,5EPS after dilution, SEK-0,46-2,82-1,39-5,34-7,6Cash and cash equivalents at end of the period67,02,567,02,58,5 “Intensive period with increased production to ChromoGenics’ largest order to date and a faster tempo in the market preparation!” Comments from the CEO It has been a hectic period with production and delivery of dynamic glass to Fabege’s project Grand Central Sundbyberg. A number of our earlier delivered projects were taken into operation, including Balderskolan in Skellefteå Municipality and ICEHOTEL 365 in Jukkasjärvi. During the quarter, the largest order to date was also signed. ChromoGenics will deliver approximately 600m2 of ConverLight™ dynamic glass to Atrium Ljungberg’s project Gränbystaden, Uppsala. Atrium Ljungberg has placed both the environment and corporate responsibility high on its agenda, and selected therefore ConverLight™ because of its effective solar control solution. In June, the first Dynamic Glass Academy was held at our premises in Uppsala. An event for spreading knowledge and acceptance for the company's dynamic glass at customers and stakeholders about energy efficiency and indoor comfort in building focusing on sustainability. At the end of the same month, ChromoGenics participated in Glass Performance Days, which is one of the world’s largest forum for the glass industry. We feel that the market is showing considerable interest in our products, and I am convinced that this is just the beginning of a successful journey for ChromoGenics. Our ConverLight™ dynamic glass offers property owners, architects, energy consultants, construction companies and players in the window and façade glass industry an attractive and cost-efficient solution for solar control. ConverLight™ makes it possible to let in a reasonable amount of sunlight and heat without impairing visibility. This significantly improves the indoor climate. ConverLight™ also contributes to buildings energy efficiency by reduced electricity consumption, which is high on the environmental agenda for the sustainability work of both the EU and the commercial sector. With a strengthened Board and organization, we continue to pursue a rapid expansion by investing in sales and an efficient, reliable production capacity. The considerable interest we are meeting from various market representatives confirms that our unique technology is creating good conditions for continued successful commercialization and future profitability! Thomas Almesjö, CEO Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Market Securities Act (2007:528). The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on July 21, 2017. Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation. About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. www.chromogenics.com
ChromoGenics receives great interest in ConverLight™ during the first day of the Global Industry Forum, Glass Performance Days
The largest and most important forum for the glass industry, Glass Performance Days (GPD), is scheduled this 28-30 June in Tampere, Finland. During the forum, knowledge and experiences are exchanged while the latest research results in the glass industry are presented and discussed. ChromoGenics AB (publ) participates to inform about the technology behind its patented Dynamic glass for solar control ConverLight™ and its customer benefits. On Wednesday, June 28, 2017, the doors of GPD opened, the glass industry's main forum in Finnish Tampere. The conference brings together all relevant stakeholders in the glass industry. The purpose is, inter alia, to create a platform where global networks are established and developed, experiences and research findings are exchanged as well as to enable business opportunities for the participants. "It is clear that our product is right in time. When we talk about the benefits of ConverLight™ for players in the growing market of construction projects that demand increased flexibility, design freedom combined with cost and energy efficiency, we get a very positive response," says Greger Gregard, CTO at ChromoGenics. ChromoGenics participates in GPD to spread insight about the benefits of the company's patented technology for dynamic glass, ConverLight™. During the first day of GDP, a great deal of interest has been shown for the dynamic solar control system, which has a number of advantages for both the indoor climate and the environment. "This is a very good opportunity for us to introduce our unique technology. There have already been several interesting meetings and it is exciting to be part of an industry where an optimistic future is seen by all participants. We take the opportunity to establish new and deepen existing relationships with relevant decision makers and business partners," concludes Thomas Almesjö, CEO of ChromoGenics. About GPD Glass Performance Days (GPD) is a forum for the development of the global glass industry through exchange of knowledge. This is done by organizing conferences in different countries. At present, the conferences are held in Finland, China and Brazil every second year. In Finland, GPD also organizes workshops and a glass exhibition. The GPD celebrates its 25th anniversary this year in Finnish Tampere on 28-30 June 2017. https://gpd.fi/events/gpd-finland-2017/ Contact: Thomas Almesjö, CEO Susanne Andersson, CFO & Head of Communications Tel: +46 18 430 0430 E-mail: info@chromogenics.com About ChromoGenics ChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.